Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study-Reference-Cited by-同舟云学术

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

Published:2013-04 Issue:4 Volume:12 Page:357-367
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Villemagne Victor L,Burnham Samantha,Bourgeat Pierrick,Brown Belinda,Ellis Kathryn A,Salvado Olivier,Szoeke Cassandra,Macaulay S Lance,Martins Ralph,Maruff Paul,Ames David,Rowe Christopher C,Masters Colin L

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference35 articles.

1. Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease;Blennow;Arch Neurol,2012

2. Comparison of pharmacokinetics, pharmacodynamics, safety, and tolerability of the amyloid β monoclonal antibody solanezumab in Japanese and white patients with mild to moderate alzheimer disease;Uenaka;Clin Neuropharmacol,2012

3. Testing the right target and right drug at the right stage;Sperling;Sci Transl Med,2011

4. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease;Jack;Ann Neurol,2012

5. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade;Jack;Lancet Neurol,2010

Cited by 1806 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tailoring near-infrared amyloid-β probes with high-affinity and low background based on CN and amphipathic regulatory strategies and in vivo imaging of AD mice;Talanta;2025-01

2. Heterogeneity of cerebral atrophic rate in mild cognitive impairment and its interactive association with proteins related to microglia activity on longitudinal cognitive changes;Archives of Gerontology and Geriatrics;2024-12

3. Tau pathology mediated the plasma biomarkers and cognitive function in patients with mild cognitive impairment;Experimental Gerontology;2024-10

4. Edaravone N-benzyl pyridinium derivatives: BACE-1 inhibition, kinetics and in silico binding pose determination;European Journal of Pharmaceutical Sciences;2024-10

5. Drug Target to Alleviate Mitochondrial Dysfunctions in Alzheimer’s Disease: Recent Advances and Therapeutic Implications;Current Neuropharmacology;2024-10